http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106905191-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate | 2017-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106905191-B |
| titleOfInvention | A kind of nitrogen mustards compound and its preparation method and application containing hydroxamic acid group |
| abstract | A kind of nitrogen mustards compound and its preparation method and application containing hydroxamic acid group is related to field of medicinal chemistry.Such compound has the ability for inhibiting cancer cell multiplication, achievees the purpose that treating cancer.Especially there is to inhibition Human skin melanoma A375, human cervical carcinoma cell HeLa, human liver cancer cell HepG2, human lung cancer cell A549, human colon cancer cell HCT116 the activity of excellent inhibition cancer cell multiplication.The compound has structure shown in general formula I, wherein X 1 、X 2 、X 3 、X 4 It is for example defined in specification with Z. |
| priorityDate | 2017-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.